257 related articles for article (PubMed ID: 33336275)
1. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
[TBL] [Abstract][Full Text] [Related]
2. Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene.
Gasparello J; Manicardi A; Casnati A; Corradini R; Gambari R; Finotti A; Sansone F
Sci Rep; 2019 Feb; 9(1):3036. PubMed ID: 30816154
[TBL] [Abstract][Full Text] [Related]
3. Peptide Nucleic Acids for MicroRNA Targeting.
Gambari R; Gasparello J; Fabbri E; Borgatti M; Tamanini A; Finotti A
Methods Mol Biol; 2020; 2105():199-215. PubMed ID: 32088872
[TBL] [Abstract][Full Text] [Related]
4. Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs.
Brognara E; Fabbri E; Bianchi N; Finotti A; Corradini R; Gambari R
Methods Mol Biol; 2014; 1095():165-76. PubMed ID: 24166312
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
Quijano E; Bahal R; Ricciardi A; Saltzman WM; Glazer PM
Yale J Biol Med; 2017 Dec; 90(4):583-598. PubMed ID: 29259523
[TBL] [Abstract][Full Text] [Related]
7. miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.
Fabbri E; Brognara E; Borgatti M; Lampronti I; Finotti A; Bianchi N; Sforza S; Tedeschi T; Manicardi A; Marchelli R; Corradini R; Gambari R
Epigenomics; 2011 Dec; 3(6):733-45. PubMed ID: 22126292
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.
Lu Z; Paolella BR; Truex NL; Loftis AR; Liao X; Rabideau AE; Brown MS; Busanovich J; Beroukhim R; Pentelute BL
ACS Chem Biol; 2020 Jun; 15(6):1358-1369. PubMed ID: 32348107
[TBL] [Abstract][Full Text] [Related]
9. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
Gambari R
Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
[TBL] [Abstract][Full Text] [Related]
10. miR-7 Knockdown by Peptide Nucleic Acids in the Ascidian
Mercurio S; Cauteruccio S; Manenti R; Candiani S; Scarì G; Licandro E; Pennati R
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623150
[TBL] [Abstract][Full Text] [Related]
11. Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.
Gasparello J; Papi C; Zurlo M; Volpi S; Gambari R; Corradini R; Casnati A; Sansone F; Finotti A
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631335
[TBL] [Abstract][Full Text] [Related]
12. Cellular delivery of peptide nucleic acid (PNA).
Koppelhus U; Nielsen PE
Adv Drug Deliv Rev; 2003 Feb; 55(2):267-80. PubMed ID: 12564980
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology for delivery of peptide nucleic acids (PNAs).
Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
[TBL] [Abstract][Full Text] [Related]
14. Peptide nucleic acids: a review on recent patents and technology transfer.
Gambari R
Expert Opin Ther Pat; 2014 Mar; 24(3):267-94. PubMed ID: 24405414
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).
Fabbri E; Manicardi A; Tedeschi T; Sforza S; Bianchi N; Brognara E; Finotti A; Breveglieri G; Borgatti M; Corradini R; Marchelli R; Gambari R
ChemMedChem; 2011 Dec; 6(12):2192-202. PubMed ID: 22012891
[TBL] [Abstract][Full Text] [Related]
16. Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold.
Zhao XL; Chen BC; Han JC; Wei L; Pan XB
Sci Rep; 2015 Nov; 5():17640. PubMed ID: 26612536
[TBL] [Abstract][Full Text] [Related]
17. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
Torres AG; Threlfall RN; Gait MJ
Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
[TBL] [Abstract][Full Text] [Related]
18. Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.
Moccia M; Adamo MF; Saviano M
Artif DNA PNA XNA; 2014 Dec; 5(3):e1107176. PubMed ID: 26752710
[TBL] [Abstract][Full Text] [Related]
19. Preparation of Anti-miR PNAs for Drug Development and Nanomedicine.
Manicardi A; Gambari R; de Cola L; Corradini R
Methods Mol Biol; 2018; 1811():49-63. PubMed ID: 29926445
[TBL] [Abstract][Full Text] [Related]
20. A Peptide Nucleic Acid (PNA) Masking the miR-145-5p Binding Site of the 3'UTR of the Cystic Fibrosis Transmembrane Conductance Regulator (
Sultan S; Rozzi A; Gasparello J; Manicardi A; Corradini R; Papi C; Finotti A; Lampronti I; Reali E; Cabrini G; Gambari R; Borgatti M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
